Free for all participants.
This webinar will discuss a range of critical topics essential for laboratory billing, coding, and compliance. Key areas of focus will include understanding and navigating National Correct Coding Initiative (NCCI) edits, reviewing newly released CPT codes, exploring important updates from Medicare Manuals, and discussing the process for submitting LCD Reconsideration Requests. Additionally, we will share insights into the latest priorities outlined in the OIG Workplan, helping organizations stay informed and aligned with federal expectations.
Peter Duda
Director of Revenue Cycle
Department of Laboratory Medicine and Pathology
Mayo Clinic, Rochester, Minnesota
Cheryl James
Manager, Lab Coding
Department of Laboratory Medicine and Pathology
Mayo Clinic, Rochester, Minnesota
Cathy Patterson
Regulatory Process Manager
Integrity and Compliance Office
Mayo Clinic, Rochester, Minnesota
Upon completion of this activity, participants should be able to:
This webinar is appropriate for laboratory administrators and managers, laboratory billing and coding professionals, and regulatory and compliance staff.
The following types of credit are offered for this event:
Mayo Clinic Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E.® program. This program has been approved for a maximum of 1.0 P.A.C.E.® contact hour.
Mayo Clinic Laboratories is approved as a Continuing Education Accrediting Agency for the Clinical Laboratory Sciences for the State of Florida. Florida Board of Clinical Laboratory Personnel has designated this program for Supervisor/Administration, Quality Control/Quality Assurance, and Safety credit credit. This program has been approved for 1.0 contact hour.
1. Register for and participate in the program.
2. Complete the evaluation that will be sent to you after the program.
3. Generate and print your certificate(s).
Level of instruction for this program is basic.
Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.
Contact us: mcleducation@mayo.edu